Project Description

Exelon

The world’s first patch for treating Alzheimer’s disease

Partner: Novartis
Active substance: Rivastigmine
Doses: 4.6 mg; 9.5 mg; 13.3 mg
Technology: Multi-layer patch
Application time: 24 hours